Y10S 530/80
Antihypertensive peptides
Y10S530/80 (Antihypertensive peptides) appears on 104 US grants and 14 published applications in this corpus.
Search patents in Y10S- Granted patents
- 104
- Published applications
- 14
- Assignees
- 48
- Inventors
- 195
- Latest grant
- 25 May 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 4 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 4 | 0 |
| 1983 | 4 | 0 |
| 1984 | 15 | 0 |
| 1985 | 18 | 0 |
| 1986 | 6 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 6 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 2 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 2 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 1 | 1 |
| 2016 | 2 | 0 |
| 2017 | 0 | 2 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
| 2022 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP25 May 2021US 11,016,106 B2Nexus Dx, Inc.
- Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent22 Dec 2020US 10,870,693 B2OncoMed Pharmaceuticals, Inc.
- Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent29 May 2018US 9,982,042 B2OncoMed Pharmaceuticals, Inc.
- Therapeutic combination and methods of treatment with a DLL4 antagonist and an anti-hypertensive agent6 Dec 2016US 9,511,139 B2OncoMed Pharmaceuticals, Inc.
- Polyclonal-monoclonal ELISA assay for detecting N-terminus pro-BNP21 Jun 2016US 9,371,382 B2Nexus Dx, Inc.
- Polyclonal-monoclonal elisa assay for detecting n-terminus pro-bnp31 Mar 2022US 2022/0099687 A1Nexus Dx, Inc.
- Therapeutic combination and methods of treatment wtih a dll4 antagonist and an anti-hypertensive agent6 Dec 2018US 2018/0346556 A1OncoMed Pharmaceuticals, Inc.
- Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent15 Jun 2017US 2017/0166632 A1OncoMed Pharmaceuticals, Inc.
- Polyclonal-monoclonal elisa assay for detecting n-terminus pro-bnp12 Jan 2017US 2017/0010288 A1Nexus Dx, Inc.
- Therapeutic Combination and Methods of Treatment With A DLL4 Antagonist and an Anti-Hypertensive Agent30 Apr 2015US 2015/0118232 A1OncoMed Pharmaceuticals, Inc.
Most cited
By later US patents
- Aminoacid derivatives as antihypertensives354US 4,374,829 AMerck & Co., Inc. · 1983
- Hypotensive peptides and their use161US 4,548,926 ASankyo Company, Limited · 1985
- Hydroxy substituted peptide compounds142US 4,514,391 AE. R. Squibb & Sons, Inc. · 1985
- Angiotensin-II analogues with antagonizing effects, containing an ester group in position 8, and a process for the preparation thereof62US 4,388,304 ARichter Gedeon Vegyeszeti Gyar Rt. · 1983
- Endothelin antagonistic cyclic pentapeptides61US 5,114,918 ABanyu Pharmaceutical Co., Ltd. · 1992